Class struggle: Expression profiling and categorizing cancer

Pharmacogenomics Journal

Volumn 3, Issue 5, 2003, Pages 257-260

  Covitz, P A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGONUCLEOTIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CANCER CLASSIFICATION; CHROMOSOME ABERRATION; CLINICAL FEATURE; CLINICAL STUDY; DNA MICROARRAY; DRUG MECHANISM; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; T CELL LEUKEMIA;

EID: 0242407563     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500187     Document Type: Article

References (28)

1. Fragoso G, Personal communication. NCI Thesaurus, 2002; http://nciterms.nci.nih. gov.
2. Fragoso G, Personal communication. NCI Metathesaurus, 2002; http://ncimeta.nci.-nih. gov.
3. Fritz A et al. (eds). International Classification of Diseases for Oncology (ICD-O). World Health Organization: Geneva, 2000.
4. Jaffe ES et al. (eds). Pathology and Genetics of Tumours of Hoematopoietic and Lymphoid Tissues. World Health Organization: Geneva, 2001.
5. Coiffier B. Curr Opin Oncol 2001; 13: 325-334.
6. Fisher RI et al. N Engl J Med 1993; 328: 1002-1006.
7. Alizadeh A et al. Cold Spring Harb Symp Quant Biol 1999; 64: 71-78.
8. Alizadeh AA et al. Nature 2000; 403: 503-511.
9. Rosenwald A et al. N Engl J Med 2002; 346: 1937-1947.
10. Shipp MA et al. Nat Med 2002; 8: 68-74.
11. Slonim DK. Nat Genet 2002; 32 (Suppl 2): 502-508.
12. Chuaqui RF et al. Nat Genet 2002; 32 (Suppl): 509-514.
13. Pui CH, Evans WE N Engl J Med 1998; 339: 605-615.
14. Yeoh EJ et al. Cancer Cell 2002; 1: 133-143.
15. Ferrando AA et al. Cancer Cell 2002; 1: 75-87.
16. Perou CM et al. Nature 2000; 406: 747-752.
17. Garber ME et al. Proc Natl Acad Sci USA 2001; 98: 13784-13789.
18. Lander ESJ et al. Nature 2001; 409: 860-921.
19. Shoemaker DD et al. Nature 2001; 409: 922-927.
20. Rosai J. Mod Pathol 2001; 14: 258-260.
21. Harris NL et al. Ann Oncol 2000; 11 (Suppl 1): 3-10.
22. Chung CH et al. Nat Genet 2002; 32 (Suppl 2): 533-540.
23. Baldwin AS. J Clin Invest 2001; 107: 241-246.
24. Adams J et al. Invest New Drugs 2000; 18: 109-121.
25. Davis RE et al. J Exp Med 2001; 194: 1861-1874.
26. Stoeckert Jr CJ et al. Nat Genet 2002; 32(Suppl): 469-473.
27. Gene Expression Data Portal. National Cancer Institute, 2003; http://gedp.nci.nih.gov.
28. Rosenwald A, Staudt LM. Semin Oncol 2002; 29: 258-263.